The estimated Net Worth of Joseph V Vumbacco is at least $1.75 Milhão dollars as of 9 August 2012. Joseph Vumbacco owns over 1,500 units of Idexx Laboratories stock worth over $1,745,326 and over the last 14 years Joseph sold IDXX stock worth over $0.
Joseph has made over 2 trades of the Idexx Laboratories stock since 2012, according to the Form 4 filled with the SEC. Most recently Joseph exercised 1,500 units of IDXX stock worth $93,465 on 9 August 2012.
The largest trade Joseph's ever made was exercising 1,500 units of Idexx Laboratories stock on 9 August 2012 worth over $93,465. On average, Joseph trades about 427 units every 28 days since 2010. As of 9 August 2012 Joseph still owns at least 3,560 units of Idexx Laboratories stock.
You can see the complete history of Joseph Vumbacco stock trades at the bottom of the page.
Joseph's mailing address filed with the SEC is ONE IDEXX DRIVE, , WESTBROOK, ME, 04092.
Over the last 21 years, insiders at Idexx Laboratories have traded over $238,711,289 worth of Idexx Laboratories stock and bought 24,695 units worth $3,109,424 . The most active insiders traders include Stuart Essig, Johnny D Powers, eJonathan W Ayers. On average, Idexx Laboratories executives and independent directors trade stock every 9 days with the average trade being worth of $4,641,291. The most recent stock trade was executed by M Anne Szostak on 5 September 2024, trading 500 units of IDXX stock currently worth $234,685.
idexx laboratories, inc. (nasdaq: idxx) is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. headquartered in southern maine, idexx conducts operations through more than 70 locations around the world, serves customers in over 175 countries, and employs more than 6,000 people. idexx's primary business focuses on pet health, a growing market around the world. idexx products —in-clinic diagnostic tests and instrumentation, reference laboratory and telemedicine consultation services, and practice management software—enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices. idexx also develops and manufactures diagnostic tests and information for the global production animal industry, including poultry and livestock, as well as tests for the quality and safety of water an
Idexx Laboratories executives and other stock owners filed with the SEC include: